Staff Scientist – Extracellular Vesicle and T Cell Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 14 hours ago

Staff Scientist – Extracellular Vesicle and T Cell Research

City of Hope is at the forefront of groundbreaking research, changing lives in the fight against cancer and diabetes. The Staff Scientist will focus on immunology and diabetes research, particularly Type 1 Diabetes, and will be responsible for project development in a translational research setting.

AssociationEducationHealth Care
check
Comp. & Benefits
Hiring Manager
Matthew Craven, CSM, RACR
linkedin

Responsibilities

Be proficient in immunology and diabetes research, particularly Type 1 Diabetes (T1D)
Have an expertise in EV biology and perform skills such as isolation, purification and functional study
Effectively develop projects in a translational research environment to meet project goals

Qualification

Immunology researchDiabetes researchExtracellular vesicle biologyMesenchymal stem cell researchLaboratory experiment designGrant application preparationScientific publicationOral communicationWritten communication

Required

A Ph.D. with a minimum of two years of mesenchymal stem cell research and extracellular vesicle (EV) research experience
Must have the ability to design and execute laboratory experiments, critically interpret experimental results, and present data in a clear and concise manner
Ability to participate in the preparation of grant applications, scientific publications, and IND submissions
Excellent oral and written communication skills
Demonstrated publication record in peer-reviewed scientific journals

Preferred

Be proficient in immunology and diabetes research, particularly Type 1 Diabetes (T1D)
Have an expertise in EV biology and perform skills such as isolation, purification and functional study
Effectively develop projects in a translational research environment to meet project goals

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase